The Ethical Management Guidelines for the Shanghai Disease-Based Biobank Network are intended to safeguard the interests of all the participants, to standardize the construction, management, and resource sharing of the Shanghai Disease-based Biobank Network, to promote the development of medical research, and to improve public health and well-being. The guidelines contain seven chapters: General Principles; Informed Consent; Use of Bio-samples from Persons without the Capacity to Consent; Privacy and Confidentiality; Applications of Use of Biological Samples and Data; Intellectual Property and Resource Sharing; and Conflict of Interest.
National Bioethics Advisory Commission Research Involving Human Biological Material: Ethical Issues and Policy Guidance. Rockville: US Government Printing Office. 1999. https://bioethicsarchive.georgetown.edu/nbac/hbm.pdf.
Independent Ethics Committee of Shanghai Clinical Research Center, Ethical Management Guidelines for the Shanghai Disease-Based Biobank, Medicine and Philosophy. 2014; 35:84–86.
World Health Organization, International Agency for Research Cancer: Common Minimum Technical Standards and Protocol for Biological Resource Centers Dedicated to Cancer Research, 2007. http://ibb.iarc.fr/standards/index.php.
17.
Office of Biorepositories and Biospecimen Research, National Cancer Institute, National Institutes of Health U.S, Department of Health and Human Services, National Cancer Institute Best Practices for Biospecimen Resources, 2011. http://biospecimens.cancer.gov/bestpractices/2011-NCIBestPractices.pdf.
